Trials / Conditions / Central Centrifugal Cicatricial Alopecia

Central Centrifugal Cicatricial Alopecia

11 registered clinical trials studyying Central Centrifugal Cicatricial Alopecia — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Al NCT07487948	Icahn School of Medicine at Mount Sinai	Phase 2
Not Yet Recruiting	Deucravacitinib in the Treatment of Cicatricial Alopecias NCT07508488	Icahn School of Medicine at Mount Sinai	Phase 2
Not Yet Recruiting	Effect of Platelet-Rich Plasma Versus Placebo in the Treatment of Central Centrifugal Cicatricial Alopecia NCT06998433	Baylor College of Medicine	Phase 4
Active Not Recruiting	Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA) NCT05416333	Wake Forest University Health Sciences	EARLY_Phase 1
Withdrawn	Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA) NCT05416320	Wake Forest University Health Sciences	EARLY_Phase 1
Completed	A Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia NCT05759338	Wake Forest University Health Sciences	N/A
Recruiting	A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia NCT04764331	Wake Forest University Health Sciences	N/A
Completed	Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling NCT04342091	Yale University	N/A
Completed	Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA) NCT03521687	Icahn School of Medicine at Mount Sinai	Phase 4
Completed	Barriers to Care and QOL for CCCA Patients NCT03044782	Northwestern University	—
Completed	Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia NCT03346668	University of Minnesota	EARLY_Phase 1